Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,194.7
20.5 (0.65%)

 

  • STI Straits Times Index
    3,194.7
    20.5 (0.65%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.4
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,498.4
    281.3 (1.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,912.0
    12.5 (0.43%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,354.4
    54.3 (0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,186.9
    34.8 (0.56%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,081.8
    21.1 (1.02%)
    Index delayed 20 minutes
  • XAO XAO
    6,813.5
    22.4 (0.33%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 718.9M
  • Value: 1,161.4M
  • Rise: 142
  • Fall: 133
  • Unch: 551

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.220-0.010
YZJ Shipbldg SGD1.110+0.010
Rex Intl0.169-0.005
Tritech0.024-0.002
SingTel3.430+0.020
OCBC Bank10.710+0.060
Genting Sing0.920+0.005
Mapletree Log Tr1.740+0.020
Mapletree NAC Tr1.180+0.030
ThaiBev0.900+0.005

World Indices

World Indices
Name Last Change
Nasdaq 8,570.7 +4.0
HSI 26,498.4 +281.3
HSCEI 10,407.2 +85.3
Jakarta 6,186.9 +34.8
Nikkei 225 23,354.4 +54.3
SSE Comp 2,912.0 +12.6
Shanghai A 3,051.3 +13.1
Shanghai B 243.4 +1.8
PSE Comp 0.0
KOSPI 2,081.8 +21.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CATALYST BIOSCIENCES INC CATALYST BIOSCIENCES
Updated on 05 Dec 2019 (End of trading day)
Last (USD): 5.040 Change: -0.180 High: 5.252 Remarks: -
Change (%): -3.45 Low: 5.010
Open 5.240 Yesterday's Close 5.22
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 97,313 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.49606 Trailing EPS (USD) e -4.35230 NAV (USD) b 6.7496
PE a - Trailing PE f - Price / NAV b 0.7467
Dividend (USD) d - Cash In Hand (USD) g 1.9116 Issued & Paid-up Shares c 12,041,000
Dividend Yield (%) d - Price / Cash In Hand g 2.637 Treasury Shares h -
Beta - 75 Daysi -1.471 R-Squared - 75 Days(%)i 6.50 Market Cap (M) 60.687
Beta - 500 Daysi -0.215 R-Squared - 500 Days (%)i 0.22 Enterprise Value (M) -22.348
Piotroski F Score 2 Exchange Code CBIO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.98 Free Float (%) 91.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 20 Aug 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CATALYST BIOSCIENCES INC NASDAQ 60.687 - - 0.7467 -
Industry Biotechnology NASDAQ 2,315.531 398.751 168.111 5.7928 0.755
Local Peer AMGEN INC NASDAQ 138,688.487 16.522 17.192 12.6923 2.397
Local Peer GILEAD SCIENCES INC NASDAQ 83,411.340 15.291 30.973 4.0483 3.504
Local Peer VERTEX PHARMACEUTICAL NASDAQ 57,362.450 27.362 26.758 10.9191 -
Local Peer BIOGEN INC NASDAQ 54,022.530 12.193 10.012 3.8599 -
Local Peer ILLUMINA INC NASDAQ 47,012.070 56.915 48.317 10.5907 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 40,442.248 16.545 18.861 3.8500 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,771.079 306.328 16.168 2.2929 -
Local Peer INCYTE CORPORATION NASDAQ 20,245.164 184.900 49.993 8.3570 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,079.584 - - 11.2832 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,384.370 - - 4.6787 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 13,850.403 - - 8.6183 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 13,552.263 - 43.666 4.9032 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), VIELA BIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), ALECTOR INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), RADIUS HEALTH INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CORTEXYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), VANDA PHARMACE INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AVROBIO INC (NASDAQ), AGENUS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), XBIOTECH INC (NASDAQ), MACROGENICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), ARDELYX INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ANAPTYSBIO INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), RECRO PHARMA INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), COMPUGEN (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVID BIOSERVICES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), GERON CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), KAMADA (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), ATHERSYS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NANTKWEST INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CHIMERIX INC (NASDAQ), IMV INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), SESEN BIO INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), INFLARX N V (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), OTONOMY INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), VACCINEX INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VERMILLION INC (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CURIS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SAVARA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), RESTORBIO INC (NASDAQ), ORGENESIS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), BIOCARDIA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SENESTECH INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ADVAXIS INC (NASDAQ), PRECIPIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VAXART INC (NASDAQ), TOCAGEN INC (NASDAQ), OCUGEN INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), TROVAGENE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Global Peer CSL ASX 127,536.908 47.537 47.537 17.0432 0.944
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,230.926 79.844 23.558 5.3140 0.751
Global Peer SINO BIOPHARM HKEx 133,071.382 12.419 12.889 3.9630 0.692
Global Peer WUXI BIO HKEx 117,659.172 157.529 123.151 12.1115 -
Global Peer BEIGENE HKEx 91,144.197 - - 9.0939 -
Global Peer GENSCRIPT BIO HKEx 36,803.239 221.324 - 10.3784 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 28,346.065 18.738 22.807 2.7938 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,714.390 43.292 631.253 2.6226 -
Other Global Peers HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), VIVA BIOTECH (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), POLYNOVO LIMITED (ASX), MESOBLAST LTD (ASX), KADMON HLDGS INC (NYSE), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), DPHARMA (Bursa), BBI LIFE SCI (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), NANOVIRICIDES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), RESAPP HEALTH LIMITED (ASX), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), PALATIN TECHNOLOGIES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), PYC THERAPEUTICS LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), PORT (SET), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENT PACIFIC (HKEx), NOVITA HEALTHCARE LTD (ASX), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), IBIO INC (NYSE American), BIOTRON (ASX), RHINOMED LIMITED (ASX), EXTRAWELL PHAR (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANTEOTECH LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), REGENEUS LTD (ASX), IMMURON LIMITED (ASX), CELLMID LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), ALTERITY THERAPEUTICS LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), GENETIC TECHNOLOGIES (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), MEGASUN (Bursa), CCP TECHNOLOGIES LTD (ASX), MEDIBIO LIMITED (ASX), MGRC (Bursa), AUSTRALIAN PRIMARY HEMP LTD (ASX), HAO WEN HLDGS (HKEx), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.410
-7.52 %
10 Days --0.500
-9.03 %
20 Days --0.660
-11.58 %
Medium Term Return 3 Months --1.140
-18.45 %
6 Months --2.040
-28.81 %
1 Year --5.180
-50.68 %
Long Term Return 2 Years --2.500
-33.16 %
3 Years --5.162
-50.60 %
Annualised Return Annualised --
-20.95 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.520 - 10.840 Change From 1 Year Low +0.520 % Change From 1 Year Low (%) +11.50
Change From 1 Year High -5.800 % Change From 1 Year High (%) -53.51
2 Years Range 4.520 - 37.000 Change From 2 Years Low +0.520 % Change From 2 Years Low (%) +11.50
Change From 2 Years High -31.960 % Change From 2 Years High (%) -86.38
5 Years Range 3.110 - 324.000 Change From 5 Years Low +1.930 % Change From 5 Years Low (%) +62.06
Change From 5 Years High -318.960 % Change From 5 Years High (%) -98.44
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
05 Dec 2019 5.240 5.252 5.010 5.040 97,313 -
04 Dec 2019 5.520 5.520 5.120 5.220 151,126 -
03 Dec 2019 5.440 5.505 5.420 5.480 46,479 -
02 Dec 2019 5.520 5.610 5.320 5.520 43,457 -
29 Nov 2019 5.390 5.478 5.270 5.450 36,442 -
27 Nov 2019 5.330 5.530 5.310 5.430 73,481 -
26 Nov 2019 5.410 5.630 5.180 5.360 111,259 -
25 Nov 2019 5.600 5.710 5.380 5.420 128,470 -
22 Nov 2019 5.260 5.600 5.210 5.540 54,203 -
21 Nov 2019 5.240 5.320 5.190 5.240 29,689 -
20 Nov 2019 5.230 5.400 5.140 5.190 71,354 -
19 Nov 2019 5.280 5.420 5.160 5.170 85,111 -
18 Nov 2019 5.330 5.490 5.180 5.210 149,472 -
15 Nov 2019 5.420 5.510 5.280 5.290 108,438 -
14 Nov 2019 5.310 5.440 5.120 5.340 144,009 -
13 Nov 2019 5.400 5.540 5.130 5.270 59,377 -
12 Nov 2019 5.720 5.780 5.390 5.390 29,573 -
11 Nov 2019 5.690 5.830 5.580 5.760 55,903 -
08 Nov 2019 5.450 5.700 5.450 5.700 72,712 -
07 Nov 2019 5.730 5.820 5.470 5.560 48,307 -
06 Nov 2019 5.830 5.840 5.611 5.740 90,021 -
05 Nov 2019 5.730 5.970 5.640 5.830 110,541 -
Summary
Current 2 Weeks
(21 Nov 2019 to 05 Dec 2019)
5.240 5.710 5.010 5.040 771,919 -
Previous 2 Weeks
(07 Nov 2019 to 20 Nov 2019)
5.730 5.820 5.010 5.190 824,256 -
4 Weeks from
(10 Oct 2019 to 06 Nov 2019)
5.250 5.710 5.010 5.740 2,200,305 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.